Publication date: Dec 17, 2018
Inflammatory bowel diseases (IBD) are chronic and recurrent inflammatory disorders of the gastrointestinal tract. The elucidation of their etiopathology requires complex and multiple approaches. Systems biology has come to fulfill this need in approaching the pathogenetic mechanisms of IBD and its etiopathology, in a comprehensive way, by combining data from different scientific sources. In combination with bioinformatics and network medicine, it uses principles from computer science, mathematics, physics, chemistry, biology, medicine and computational tools to achieve its purposes. Systems biology utilizes scientific sources that provide data from omics studies (e.g., genomics, transcriptomics, etc.) and clinical observations, whose combined analysis leads to network formation and ultimately to a more integrative image of disease etiopathogenesis. In this review, we analyze the current literature on the methods and the tools utilized by systems biology in order to cover an innovative and exciting field: IBD-omics.
Open Access PDF
Dovrolis, N., Filidou, E., and Kolios, G. Systems biology in inflammatory bowel diseases: on the way to precision medicine. 04528. 2018 Ann Gastroenterol (32):3.
|disease||DOID||age related macular degeneration|
|disease||MESH||age related macular degeneration|
|disease||MESH||inflammatory bowel diseases|
- What did we learn from multiple omics studies in asthma?
- From Genomics to Multi-Omics: African American Precision Medicine – Minoli Perera
- Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapy.